Disruption of intracerebral progression of C6 rat glioblastoma by in vivo treatment with anti-CD44 monoclonal antibody

scientific article published in January 2000

Disruption of intracerebral progression of C6 rat glioblastoma by in vivo treatment with anti-CD44 monoclonal antibody is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3171/JNS.2000.92.1.0140
P8608Fatcat IDrelease_i6vqddsuhne6ljpnojcxqmyfxq
P698PubMed publication ID10616093

P2093author name stringSamii M
Hussein S
Walter GF
Hecker H
Gunia S
Radu DL
Stan AC
Breyer R
Pütz KM
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectantibodyQ79460
glioblastomaQ282142
P304page(s)140-149
P577publication date2000-01-01
P1433published inJournal of NeurosurgeryQ15708886
P1476titleDisruption of intracerebral progression of C6 rat glioblastoma by in vivo treatment with anti-CD44 monoclonal antibody
P478volume92

Reverse relations

cites work (P2860)
Q57174079A three-dimensional (3D) organotypic microfluidic model for glioma stem cells - Vascular interactions
Q53702204Association of Glioblastoma Multiforme Stem Cell Characteristics, Differentiation, and Microglia Marker Genes with Patient Survival
Q33874532Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level
Q28344466Bromelain Reversibly Inhibits Invasive Properties of Glioma Cells
Q45115252CD44 expression in human gliomas
Q35580052CD44: molecular interactions, signaling and functions in the nervous system
Q26752312Cancer Stem Cell Hierarchy in Glioblastoma Multiforme
Q33779328Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
Q37715009Chapter 11 - Solid lipid nanoparticles for brain tumors therapy: State of the art and novel challenges
Q59335725Convective forces increase CXCR4-dependent glioblastoma cell invasion in GL261 murine model
Q97543194Dissecting and rebuilding the glioblastoma microenvironment with engineered materials
Q36764016Emerging monoclonal antibody therapies for malignant gliomas
Q35119166Expression of the Transmembrane Glycoprotein CD44s Is Potentially an Independent Predictor of Recurrence in Hepatocellular Carcinoma.
Q31031124Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis
Q89884132High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas
Q36578627Hyaluronan as a therapeutic target in human diseases
Q90621253Hyaluronic Acid: Incorporating the Bio into the Material
Q48177863Intralesional radioimmunotherapy in the treatment of malignant glioma: clinical and experimental findings
Q34566436Migration and invasion in brain neoplasms
Q38405896Modulation of hyaluronan production by CD44 positive glioma cells
Q40094413PKC-induced stiffening of hyaluronan/CD44 linkage; local force measurements on glioma cells
Q36021591Perspectives of cellular and molecular neurosurgery
Q36825153Solid lipid nanoparticles: could they help to improve the efficacy of pharmacologic treatments for brain tumors?
Q44132046The hyaluronan receptor RHAMM/IHABP in astrocytoma cells: expression of a tumor-specific variant and association with microtubules
Q49791669Truncated glioma-associated oncogene homolog 1 (tGLI1) mediates mesenchymal glioblastoma via transcriptional activation of CD44.

Search more.